title: [Cytogenetic analysis of secondary myelodysplastic syndrome after rhabdomysarcoma treatment--case report].
abstract: Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma. Alveolar subtype of RMS is characterized by very poor prognosis and intensive chemotherapy, radiotherapy and surgery often failed. Frequently a secondary malignant neoplasms has been found in patients treated for primary cancer. Ten-years-old boy with RMS in the right thigh after 3 years of treatment revealed therapy related myelodysplastic syndrome and was lost to follow-up 4 months later.
authors: Zakład Diagnostyki Medycznej, Poznań. ewamaly@gmail.com
authors: Ewa
authors: E
authors: Mały
authors: Marta
authors: M
authors: Przyborska
authors: Jerzy
authors: J
authors: Nowak
authors: Danuta
authors: D
authors: Januszkiewicz-Lewandowska
mesh_terms: D002648:Child; D002872:Chromosome Deletion; D002895:Chromosomes, Human, Pair 5 / Q000235:genetics*; D003131:Combined Modality Therapy / Q000009:adverse effects; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000209:etiology* / Q000235:genetics* / Q000473:pathology; D012208:Rhabdomyosarcoma / Q000150:complications* / Q000628:therapy*; D013848:Thigh